Evidence for the production of peroxynitrite in inflammatory CNS demyelination

Journal of Neuroimmunology

Volumn 80, Issue 1-2, 1997, Pages 121-130

  Cross, Anne H ^a   Manning, Pamela T ^b   Stern, Michael K ^c   Misko, Thomas P ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Inflammatory Dis Res GD S   (United States)

^c MONSANTO COMPANY   (United States)

Author keywords

Demyelination; Experimental autoimmune (allergic) encephalomyelitis; Nitric Oxide; Peroxynitrite anion

Indexed keywords

CD4 ANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; SUPEROXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ORGANELLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; DEMYELINATION; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED STRAINS; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECURRENCE; REMISSION INDUCTION; SERUM ALBUMIN, BOVINE; SPINAL CORD; TYROSINE;

EID: 0031457801     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00145-8     Document Type: Article

References (44)

1. Al-Ramadi B.K., Meissler J.J. Jr., Huang D., Eisenstein T.K. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur. J. Immunol. 22:1992;2249-2254.
2. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
3. Beckman J.S., Ye Y.Z., Anderson P.G., Accavitti M.A., Tarpey M.M., White C.R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler. 375:1994;81-88.
4. Bo L., Dawson T.M., Wesselingh S., Mork S., Choi S., Kong P.H., Hanley D., Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 16:1994;778-786.
5. Bolanos J.B., Peuchen S., Heales S.J.R., Land J.M., Clark J.B. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63:1994;910-916.
6. Brosnan C.F., Battistini L., Raine C.S., Dickson D.W., Casadevall A., Lee S.C. Reactive nitrogen intermediates in human neuropathology: an overview. Dev. Neurosci. 16:1994;152-161.
7. Cannella B., Raine C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:1995;424-435.
8. Castro L., Rodriguez M., Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J. Biol. Chem. 269:1994;29409-29415.
9. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:1979;527-605.
10. Connor J.R., Manning P.T., Settle S.L., Moore W.M., Jerome G.M., Webber R.K., Tjoeng F.S., Currie M.G. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol. 273:1995;15-24.
11. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
12. Haddad I.Y., Pataki G., Hu P., Galliani C., Beckman J.S., Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 94:1994;2407-2413.
13. Hausladen A., Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 269:1994;29405-29408.
14. Hewett S.J., Corbett J.A., McDaniel M.L., Choi D.W. Interferon-γ and interleukin-1β induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett. 164:1993;229-232.
15. Hooper D.C., Ohnishi S.H., Kean R., Numagami Y., Dietzschold B., Koprowski H. Local nitric oxide production in viral and autoimmune disease of the central nervous system. Proc. Natl. Acad. Sci. USA. 92:1995;5312-5316.
16. Ischiropoulos H., Zhu L., Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298:1992;446-451.
17. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with expeirmental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
18. Kobayashi S., Imajoh-Ohmi S., Kuribayashi F., Nunoi H., Nakamura M., Kanegasaki S. Characterization of the superoxide-generating system in human peripheral lymphocytes and lymphoid cell lines. J. Biochem. 117:1995;758-765.
19. Lander H.M., Sehajpal P., Levine D.M., Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1993;1509-1516.
20. Lee S.C., Dickson D.W., Liu W., Brosnan C.F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-γ J. Neuroimmunol. 46:1993;19-24.
21. Leis, J.R., Pena, M.E., Rios, A., 1993. A novel route to peroxynitrite anion. J. Chem. Soc. Chem. Commun. 1298-1299.
22. Lin R.F., Lin T.S., Tilton R.G., Cross A.H. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178:1993;643-648.
23. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.V., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
24. -245 components by human tonsillar B lymphocytes and B cell lines. J. Immunol. 142:1989;1260-1267.
25. Marchetti P., Hirsch T., Zamzami N., Castedo M., Decaudin D., Susin S.A., Masse B., Kroemer G. Mitochondrial permeability transition triggers lymphocyte apoptosis. J. Immunol. 157:1996;4830-4836.
26. Martin B.B.L., Wu D., Jakes S., Graves D.J. Chemical influences on the specificity of tyrosine phosphorylation. J. Biol. Chem. 265:1990;7108-7111.
27. Melinn M., McLaughlin H. Nitroblue tetrazolium reduction in lymphocytes. J. Leuk. Biol. 41:1987;325-329.
28. Merrill J.E., Kono D.H., Clayton J., Ando D.G., Hinton D.R., Hofman F.M. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA. 89:1992;574-578.
29. Misko T.P., Trotter J.L., Cross A.H. Mediation of inflammation by encephalitogenic cells: Cytokine induction of nitric oxide synthase and cyclooxygenase 2. J. Neuroimmunol. 61:1995;195-204.
30. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
31. Patel J.M., Block E.R. Nitrogen dioxide-induced changes in cell membrane fluidity and function. Am. Rev. Respir. Dis. 134:1986;1196-1202.
32. - T lymphocytes. J. Immunol. 127:1981;1420-1423.
33. Pryor W.A., Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268:1995;L699-722.
34. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266:1991;4244-4250.
35. Raine C.S. Biology of disease. The analysis of autoimmune demyelination: its impact on multiple sclerosis. Lab. Invest. 50:1984;608-635.
36. Salvemini D., Wang Z.Q., Wyatt P.S., Bourdon D.M., Marino M.H., Manning P.T., Currie M.G. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Brit. J. Pharmacol. 118:1996;829-838.
37. Thuring H., Stenger S., Gmehling D., Rollinghoff M., Bogdan C. Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naive and Leishmania major-infected mice. Eur. J. Immunol. 25:1995;3229-3234.
38. Tran E.H., Hardin-Pouzet H., Verge G., Owens T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 74:1997;121-129.
39. Weiss, A., 1993. T lymphocyte activation. In: Paul, W.E. (Ed.), Fundamental Immunology, 3rd ed. Raven Press, New York, pp. 467-496.
40. Weiss S.J., LoBuglio A.F. Biology of disease. Phagocyte-generated oxygen metabolites and cellular injury. Lab. Invest. 47:1982;5-18.
41. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S.A., Petiti P.X., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:1995;367-377.
42. Zhao W., Tilton R.G., Corbett J.A., McDaniel M.L., Misko T.P., Williamson J.R., Cross A.H., Hickey W.F. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of inducible nitric oxide synthase. J. Neuroimmunol. 64:1996;123-133.
43. Zielasek J., Jung S., Gold R., Liew F.Y., Toyka K.V., Hartung H.P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;81-88.
44. Zingarelli B., O'Connor M., Wong H., Salzman A.L., Szabo C. Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipolysaccharide. J. Immunol. 156:1996;350-358.